Sign in
4

Changes in Ownership

Immunome Inc. Filed Acc 0001415889-25-020782

Options or other derivatives

  • President and CEO acquired 800,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
SIEGALL CLAY B President and CEO 2025-07-29 Grant or award · Employee Stock Option (right to buy) +800,000 800,000 D
Loading xslF345X05/form4-07312025_100706.xml…